GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 180 Life Sciences Corp (NAS:ATNFW) » Definitions » Loans Receivable

180 Life Sciences (180 Life Sciences) Loans Receivable : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is 180 Life Sciences Loans Receivable?

180 Life Sciences's Loans Receivable for the quarter that ended in Mar. 2024 was $0.00 Mil.


180 Life Sciences Loans Receivable Historical Data

The historical data trend for 180 Life Sciences's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

180 Life Sciences Loans Receivable Chart

180 Life Sciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
- - - - -

180 Life Sciences Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

180 Life Sciences Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


180 Life Sciences Loans Receivable Related Terms

Thank you for viewing the detailed overview of 180 Life Sciences's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


180 Life Sciences (180 Life Sciences) Business Description

Traded in Other Exchanges
Address
3000 El Camino Real, Bldg. 4, Suite 200, Palo Alto, CA, USA, 94306
180 Life Sciences Corp is a clinical-stage biotechnology company. It is focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics.

180 Life Sciences (180 Life Sciences) Headlines

From GuruFocus

Could Insider Buying Signal that 180 Life Sciences Corp Is Undervalued?

By GuruFocus Research GuruFocus Editor 05-19-2023